| Date | Form | Description | Docs | XBRL | Pages |
| 07/15/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
43 | |
| 07/15/14 | 8-K | Current report filing |
|
54 | |
| 07/14/14 | 8-K | Current report filing |
|
5 | |
| 06/26/14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 06/26/14 | DEF 14A | Definitive proxy statements |
|
59 | |
| 06/17/14 | UPLOAD | SEC-generated letter |
|
1 | |
| 06/16/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 06/16/14 | PRER14A | Preliminary revised proxy soliciting materials |
|
49 | |
| 06/16/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
63 |
| 06/13/14 | UPLOAD | SEC-generated letter |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...